nach oben

Erschienen in:

01.02.2015

Smoking Cessation Intervention Within the Framework of a Lung Cancer Screening Program: Preliminary Results and Clinical Perspectives from the “Cosmos-II” Trial

verfasst von: Lococo Filippo, Rosastella Principe, Alfredo Cesario, Giovanni Apolone, Francesco Carleo, Pasquale Ialongo, Giulia Veronesi, Giuseppe Cardillo

Erschienen in: Lung | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Data coming from the literature investigating the effectiveness and interaction between smoking cessation (SC) and lung cancer screening (LCScr) are still sparse and inconsistent. Herein, we report the preliminary results from the ongoing lung cancer screening trial (“Cosmos-II”) focusing our analysis on the inter-relationship between the SC program and the LCScr.

Centers for Disease Control and Prevention. Lung cancer: risk factors. http://www.cdc.gov/cancer/lung/basic_info/risk_factors.htm. Accessed July 2013

US Department of Health and Human Services, Centers for Disease Control and Prevention and Health Promotion, Office on Smoking and Health. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Washington, DC: USDHSS; 2014.2

US Department of Health and Human Services (2008) Treating tobacco use and dependence: 2008 update. USDHHS, Rockville

Deppen SA, Grogan EL, Aldrich MC, Massion PP (2014) Lung cancer screening and smoking cessation: a teachable moment? J Natl Cancer Inst 106(6):dju122. doi:10.1093/jnci/dju122 No abstract availablePubMedCrossRef

Joseph AM, Fu SS, Lindgren B et al (2011) Chronic disease management for tobacco dependence: a randomized, controlled trial. Arch Intern Med 171(21):1894–1900PubMedCentralPubMedCrossRef

National Comprehensive Cancer Network. Lung Cancer Screening v1.2014. NCCN Clinical Practice Guidelines in Oncology, 2014. http://www.nccn.org/professionals/physician_gls/recently_updated.asp. Accessed April 17 2014

Field JK, Smith RA, Aberle DR et al (2012) International association for the study of lung cancer computed tomography screening workshop 2011 report. J Thorac Oncol 7(1):10–19PubMedCrossRef

Ferketich AK, Otterson GA, King M, Hall N, Browning KK, Wewers ME (2012) A pilot test of a combined tobacco dependence treatment and lung cancer screening program. Lung Cancer 76(2):211–215. doi:10.1016/j.lungcan.2011.10.011.Epub PubMedCentralPubMedCrossRef

Fagerstrőm KO, Schneirder NG (1989) Measuring nicotine dependence: a review of the Fagerstrőm Tolerance Questionnaire. J Behav Med 12:159–182PubMedCrossRef

10.

Gallus S, Tramacere I, La Vecchia C, Colombo P, Zuccaro P, Paleari L, Cesario A, Russo P, Apolone G (2009) Use of pharmacotherapy for smoking cessation in Italy. Arch Intern Med 169(20):1927–1928. doi:10.1001/archinternmed.2009.354 PubMed PMID: 19901149PubMedCrossRef

11.

Munshi V, McMahon P (2013) Importance of smoking cessation in a lung cancer screening program. Curr Surg Rep 1(4):242–248. doi:10.1007/s40137-013-0030-1 CrossRef

12.

van der Aalst CM, van den Bergh KA, Willemsen MC, de Koning HJ, van Klaveren RJ (2010) Lung cancer screening and smoking abstinence: 2 year follow-up data from the Dutch–Belgian randomised controlled lung cancer screening trial. Thorax 65(7):600–605. doi:10.1136/thx.2009.133751 PubMedCrossRef

Titel: Smoking Cessation Intervention Within the Framework of a Lung Cancer Screening Program: Preliminary Results and Clinical Perspectives from the “Cosmos-II” Trial
verfasst von: Lococo Filippo
Rosastella Principe
Alfredo Cesario
Giovanni Apolone
Francesco Carleo
Pasquale Ialongo
Giulia Veronesi
Giuseppe Cardillo
Publikationsdatum: 01.02.2015
Verlag: Springer US
Erschienen in: Lung / Ausgabe 1/2015
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-014-9661-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Smoking Cessation Intervention Within the Framework of a Lung Cancer Screening Program: Preliminary Results and Clinical Perspectives from the “Cosmos-II” Trial

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2015

Comparison of LMWH Versus UFH for Hemorrhage and Hospital Mortality in the Treatment of Acute Massive Pulmonary Thromboembolism After Thrombolytic Treatment

Protective Association of TIM1−1454G>A Polymorphism with Asthma in a North Indian Population

Trends in Self-Rated Health Status and Health Services Use in COPD Patients (2006–2012). A Spanish Population-Based Survey

Diagnosis of Latent Tuberculosis Infection with T-SPOT®.TB in a Predominantly Immigrant Population with Rheumatologic Disorders

Diagnostic Value of Pleural Fluid Obtained from a Chest Tube Collection System

Acute Phase Proteins and Stress Hormone Responses in Patients with Newly Diagnosed Active Pulmonary Tuberculosis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Innere Medizin